Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.20344/amp.13957

http://scihub22266oqcxt.onion/10.20344/amp.13957
suck pdf from google scholar
32498762!ä!32498762

suck abstract from ncbi

pmid32498762      Acta+Med+Port 2020 ; 33 (7-8): 505-511
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Coronavirus Disease 2019: Clinical Review #MMPMID32498762
  • Gouveia CC; Campos L
  • Acta Med Port 2020[Jul]; 33 (7-8): 505-511 PMID32498762show ga
  • INTRODUCTION: In December 2019, an outbreak of pneumonia caused by a novel coronavirus occurred in Wuhan, the capital of Central China's Hubei Province and has been declared a public health emergency of international concern by the World Health Organization since January 2020. MATERIAL AND METHODS: A comprehensive search using the PubMed database was carried out to summarize the latest published information about the epidemiology, definition, pathogenesis, clinical characteristics, treatment options, prognosis and prevention of coronavirus disease 2019. DISCUSSION: This new strain of coronavirus, named severe acute respiratory syndrome coronavirus 2, enters human cells that express angiotensin-converting enzyme II receptors, which exist in the respiratory, gastrointestinal and genitourinary tracts and heart, causing coronavirus disease. Transmission occurs essentially through the respiratory tract and the main symptoms are fever, cough and dyspnea. Diagnosis is based on epidemiological, clinical and imaging features and confirmed by nucleic acid testing. CONCLUSION: Despite intensive research, the exact origin of the virus and pathophysiology of coronavirus disease is not yet completely known, and clinically approved vaccines and drugs that target severe acute respiratory syndrome coronavirus 2 are lacking.
  • |*Coronavirus Infections/diagnosis/drug therapy/epidemiology/transmission[MESH]
  • |*Pandemics[MESH]
  • |*Pneumonia, Viral/diagnosis/drug therapy/epidemiology/transmission[MESH]
  • |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH]
  • |Alanine/analogs & derivatives/therapeutic use[MESH]
  • |Amides/therapeutic use[MESH]
  • |Animals[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |Azithromycin/therapeutic use[MESH]
  • |Betacoronavirus/immunology/*pathogenicity[MESH]
  • |Blood Coagulation Disorders/prevention & control[MESH]
  • |COVID-19[MESH]
  • |China/epidemiology[MESH]
  • |Chiroptera/virology[MESH]
  • |Chloroquine/therapeutic use[MESH]
  • |Glucocorticoids/therapeutic use[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/therapeutic use[MESH]
  • |Infectious Disease Incubation Period[MESH]
  • |Lopinavir/therapeutic use[MESH]
  • |Lung/diagnostic imaging[MESH]
  • |Prognosis[MESH]
  • |Pyrazines/therapeutic use[MESH]
  • |Radiography, Thoracic[MESH]
  • |Reverse Transcriptase Polymerase Chain Reaction[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box